Clinical Trials Logo
  1. Home
  2. Phototherapy
  3. NCT01818154
  4. Details
NCT01818154 Clinical Trial

Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)

Phototherapy Clinical Trial

Official title:
Validation of a New Hand Held Light Emitting Diode (LED) Device for the Determination of Minimal Erythema Dose (MED) for Narrowband Ultraviolet B.

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT01818154
Other study ID # 7257
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date May 2012
Est. completion date December 2013

Study information
Verified date February 2022
Source Henry Ford Health System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to validate a new hand held light emitting diode (LED) device for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB) radiation by comparing to the traditional approach of measurement of the minimal erythema dose.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 120 Years
Eligibility Inclusion Criteria: 1. Age greater than 18 years. Exclusion Criteria: 1. Pregnancy 2. Lactation 3. History of photosensitivity disorder 4. Photosensitizing medications 5. Personal history of melanoma or non-melanoma skin cancer. 6. Skin disease on the back

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• LED phototherapy

• narrowband UVB phototherapy

Locations
Country Name City State
United States Henry Ford Medical Center Department of Dermatology Detroit Michigan

Sponsors (1)
Lead Sponsor Collaborator
Henry Ford Health System

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Minimal Erythema Dose The Investigator will look at area irradiated and evaluate for erythema. The lowest dose at which erythema is noted will be recorded as the minimal erythema dose. 1 day
See also
  Status Clinical Trial Phase
Completed NCT03566186 - Effects of Phototherapy Associated With Sprint and Squat Training on Cardiac Autonomic Modulation N/A
Recruiting NCT05556811 - HEaling LIght Algorithms for the ICU Patient N/A
Recruiting NCT03384342 - Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo N/A
Completed NCT03420391 - PBMT on Muscular Performance and Recovery in Different Time-points N/A
Completed NCT03942757 - BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator
Completed NCT04407351 - Develop Novel Phototherapy for Health Care of Patients With Sleep Disorder, Mild Cognitive Impairment, or Dementia N/A
Completed NCT03752645 - Subjects With Clinical Diagnosis of Allergic Rhinitis Were Randomly Divided Into 2 Groups, With Patients in One Group Given One Treatment Session of Red Light Rhinophototherapy, Followed by Medical Treatment. Those in the Second Group Were Treated With Medical Treatment Only. N/A
Completed NCT03570775 - Effectiveness, Safety and Perceptions With the Use of One LED Sleeping Bag Device in the Treatment of Neonatal Jaundice N/A
Completed NCT03569254 - Effectiveness, Safety and Perceptions With the Use of One LED Blanket Device in the Ambulatory Treatment of Jaundice N/A
Recruiting NCT06110520 - Violet Light for the Suppression of Myopia N/A
Recruiting NCT05949827 - Healing Light Algorithms for Nurses in the ICU
Completed NCT03695458 - Local and Systemic Effects of Photobiomodulation Therapy on Muscle Performance and Recovery Post-exercise. N/A
Completed NCT04215601 - Effect of Phototherapy on Serum Calcium
Completed NCT03728439 - Effects of Light Emitting Diodes (LED) Therapy in Rugby Athletes N/A
Enrolling by invitation NCT04636242 - Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis Phase 3